Cargando…

Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD

The definite diagnosis of human sporadic Creutzfeldt–Jakob disease (sCJD) largely depends on postmortem neuropathology and PrP(Sc) detection in the brain. The development of real-time quaking-induced conversion (RT-QuIC) of cerebrospinal fluid (CSF) samples makes it possible for premortem diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Kang, Yang, Xuehua, Zhou, Wei, Chen, Cao, Shi, Qi, Dong, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707901/
https://www.ncbi.nlm.nih.gov/pubmed/34959597
http://dx.doi.org/10.3390/pathogens10121642
_version_ 1784622551536762880
author Xiao, Kang
Yang, Xuehua
Zhou, Wei
Chen, Cao
Shi, Qi
Dong, Xiaoping
author_facet Xiao, Kang
Yang, Xuehua
Zhou, Wei
Chen, Cao
Shi, Qi
Dong, Xiaoping
author_sort Xiao, Kang
collection PubMed
description The definite diagnosis of human sporadic Creutzfeldt–Jakob disease (sCJD) largely depends on postmortem neuropathology and PrP(Sc) detection in the brain. The development of real-time quaking-induced conversion (RT-QuIC) of cerebrospinal fluid (CSF) samples makes it possible for premortem diagnosis for sCJD. To test the diagnostic potential of RT-QuIC of skin specimens for probable sCJD, we collected the paired skin and CSF samples from 51 recruited living patients referred to the Chinese CJD surveillance center, including 34 probable sCJD, 14 non-CJD, and 3 genetic prion disease (gPrD). The samples were subjected to RT-QuIC assays using recombinant hamster PrP protein rHaPrP90-231 as the substrate. Using skin RT-QuIC assay, 91.2% (31/34) probable sCJD patients, and 1 T188K genetic CJD (gCJD) cases showed positive prion-seeding activity, while 85.7% (12/14) non-CJD patients were negative. CSF RT-QuIC positive seeding activity was only observed in 14 probable sCJD patients. Analysis of the reactivity of 38 positive skin RT-QuIC tests revealed that the positive rates in the preparations of 10(−2), 10(−3) and 10(−4) diluted skin samples were 88.6% (39/44), 63.6% (28/44), and 25.0% (11/44), respectively. Eleven probable sCJD patients donated two skin specimens collected at different sites simultaneously. Although 95.5% (21/22) skin RT-QuIC elicited positive reaction, the reactivity varied. Our preliminary data indicate high sensitivity and specificity of skin RT-QuIC in prion detection for Chinese probable sCJD and highlight that skin prion-seeding activity is a reliable biomarker for premortem diagnosis of human prion disease.
format Online
Article
Text
id pubmed-8707901
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87079012021-12-25 Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD Xiao, Kang Yang, Xuehua Zhou, Wei Chen, Cao Shi, Qi Dong, Xiaoping Pathogens Article The definite diagnosis of human sporadic Creutzfeldt–Jakob disease (sCJD) largely depends on postmortem neuropathology and PrP(Sc) detection in the brain. The development of real-time quaking-induced conversion (RT-QuIC) of cerebrospinal fluid (CSF) samples makes it possible for premortem diagnosis for sCJD. To test the diagnostic potential of RT-QuIC of skin specimens for probable sCJD, we collected the paired skin and CSF samples from 51 recruited living patients referred to the Chinese CJD surveillance center, including 34 probable sCJD, 14 non-CJD, and 3 genetic prion disease (gPrD). The samples were subjected to RT-QuIC assays using recombinant hamster PrP protein rHaPrP90-231 as the substrate. Using skin RT-QuIC assay, 91.2% (31/34) probable sCJD patients, and 1 T188K genetic CJD (gCJD) cases showed positive prion-seeding activity, while 85.7% (12/14) non-CJD patients were negative. CSF RT-QuIC positive seeding activity was only observed in 14 probable sCJD patients. Analysis of the reactivity of 38 positive skin RT-QuIC tests revealed that the positive rates in the preparations of 10(−2), 10(−3) and 10(−4) diluted skin samples were 88.6% (39/44), 63.6% (28/44), and 25.0% (11/44), respectively. Eleven probable sCJD patients donated two skin specimens collected at different sites simultaneously. Although 95.5% (21/22) skin RT-QuIC elicited positive reaction, the reactivity varied. Our preliminary data indicate high sensitivity and specificity of skin RT-QuIC in prion detection for Chinese probable sCJD and highlight that skin prion-seeding activity is a reliable biomarker for premortem diagnosis of human prion disease. MDPI 2021-12-19 /pmc/articles/PMC8707901/ /pubmed/34959597 http://dx.doi.org/10.3390/pathogens10121642 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xiao, Kang
Yang, Xuehua
Zhou, Wei
Chen, Cao
Shi, Qi
Dong, Xiaoping
Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD
title Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD
title_full Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD
title_fullStr Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD
title_full_unstemmed Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD
title_short Validation and Application of Skin RT-QuIC to Patients in China with Probable CJD
title_sort validation and application of skin rt-quic to patients in china with probable cjd
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707901/
https://www.ncbi.nlm.nih.gov/pubmed/34959597
http://dx.doi.org/10.3390/pathogens10121642
work_keys_str_mv AT xiaokang validationandapplicationofskinrtquictopatientsinchinawithprobablecjd
AT yangxuehua validationandapplicationofskinrtquictopatientsinchinawithprobablecjd
AT zhouwei validationandapplicationofskinrtquictopatientsinchinawithprobablecjd
AT chencao validationandapplicationofskinrtquictopatientsinchinawithprobablecjd
AT shiqi validationandapplicationofskinrtquictopatientsinchinawithprobablecjd
AT dongxiaoping validationandapplicationofskinrtquictopatientsinchinawithprobablecjd